Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Quantitative Ultrasound Assessment of Duchenne Muscular Dystrophy Using Edge Detection Analysis.

Koppaka S, Shklyar I, Rutkove SB, Darras BT, Anthony BW, Zaidman CM, Wu JS.

J Ultrasound Med. 2016 Sep;35(9):1889-97. doi: 10.7863/ultra.15.04065. Epub 2016 Jul 14.

PMID:
27417736
2.

Central Regulation of Glucose Production May Be Impaired in Type 2 Diabetes.

Esterson YB, Carey M, Boucai L, Goyal A, Raghavan P, Zhang K, Mehta D, Feng D, Wu L, Kehlenbrink S, Koppaka S, Kishore P, Hawkins M.

Diabetes. 2016 Sep;65(9):2569-79. doi: 10.2337/db15-1465. Epub 2016 May 10.

3.

Insulin sensitizing and anti-inflammatory effects of thiazolidinediones are heightened in obese patients.

Esterson YB, Zhang K, Koppaka S, Kehlenbrink S, Kishore P, Raghavan P, Maginley SR, Carey M, Hawkins M.

J Investig Med. 2013 Dec;61(8):1152-60. doi: 10.2310/JIM.0000000000000017.

4.

Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans.

Koppaka S, Kehlenbrink S, Carey M, Li W, Sanchez E, Lee DE, Lee H, Chen J, Carrasco E, Kishore P, Zhang K, Hawkins M.

Diabetes. 2013 Jun;62(6):1843-54. doi: 10.2337/db12-0868. Epub 2013 Jan 24.

5.

Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants.

Esterson YB, Kishore P, Koppaka S, Li W, Zhang K, Tonelli J, Lee DE, Kehlenbrink S, Lawrence S, Crandall J, Barzilai N, Hawkins M.

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1321-8. doi: 10.1093/gerona/gls200. Epub 2012 Oct 22.

6.

Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Kehlenbrink S, Koppaka S, Martin M, Relwani R, Cui MH, Hwang JH, Li Y, Basu R, Hawkins M, Kishore P.

Diabetologia. 2012 Nov;55(11):3021-8. doi: 10.1007/s00125-012-2662-6. Epub 2012 Jul 31.

PMID:
22847060
7.

Xylitol prevents NEFA-induced insulin resistance in rats.

Kishore P, Kehlenbrink S, Hu M, Zhang K, Gutierrez-Juarez R, Koppaka S, El-Maghrabi MR, Hawkins M.

Diabetologia. 2012 Jun;55(6):1808-12. doi: 10.1007/s00125-012-2527-z. Epub 2012 Mar 30.

8.

Activation of K(ATP) channels suppresses glucose production in humans.

Kishore P, Boucai L, Zhang K, Li W, Koppaka S, Kehlenbrink S, Schiwek A, Esterson YB, Mehta D, Bursheh S, Su Y, Gutierrez-Juarez R, Muzumdar R, Schwartz GJ, Hawkins M.

J Clin Invest. 2011 Dec;121(12):4916-20. doi: 10.1172/JCI58035. Epub 2011 Nov 7.

9.

Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.

Kishore P, Li W, Tonelli J, Lee DE, Koppaka S, Zhang K, Lin Y, Kehlenbrink S, Scherer PE, Hawkins M.

Sci Transl Med. 2010 Feb 24;2(20):20ra15. doi: 10.1126/scitranslmed.3000292.

10.

Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Kehlenbrink S, Tonelli J, Koppaka S, Chandramouli V, Hawkins M, Kishore P.

Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E165-73. doi: 10.1152/ajpendo.00001.2009. Epub 2009 May 5.

11.

Ketones suppress brain glucose consumption.

LaManna JC, Salem N, Puchowicz M, Erokwu B, Koppaka S, Flask C, Lee Z.

Adv Exp Med Biol. 2009;645:301-6. doi: 10.1007/978-0-387-85998-9_45.

12.

Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.

Kishore P, Tonelli J, Koppaka S, Fratila C, Bose A, Lee DE, Reddy K, Hawkins M.

Diabetes. 2006 Jun;55(6):1761-8.

Supplemental Content

Loading ...
Support Center